{"entity":{"type":"insider","cik":"0001451613","url":"/insider/0001451613","json_url":"/insider/0001451613.json","name":"Theracour Pharma, Inc.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":92,"n_filings":46,"first":"2008-12-18","last":"2013-02-01","span_basis":"filed_date"},"name_variants":[{"name":"Theracour Pharma, Inc.","source":"filing","n_filings":46,"first_seen":"2008-12-18","last_seen":"2013-02-01"}],"transactions":[{"id":5483169,"accession":"0001140361-13-004245","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-13-004245","line_url":"/filing/0001140361-13-004245#line-1","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39000.0,"shares_display":"39,000","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":19500.0,"total_display":"19,500.00","total_whole":"19,500","shares_owned_after":33321000.0,"shares_owned_after_display":"33,321,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-30","filed_date":"2013-02-01","scope":"insider"},{"id":7756808,"accession":"0001140361-10-027101","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-10-027101","line_url":"/filing/0001140361-10-027101#line-1","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":353982.0,"shares_display":"353,982","price_per_share":0.565,"price_display":"0.56","price_state":"stated","total_value":199999.83,"total_display":"199,999.83","total_whole":"200,000","shares_owned_after":33006018.0,"shares_owned_after_display":"33,006,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-06-24","filed_date":"2010-06-25","scope":"insider"},{"id":6016305,"accession":"0001140361-09-028211","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-09-028211","line_url":"/filing/0001140361-09-028211#line-4","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":0.85,"price_display":"0.85","price_state":"stated","total_value":4250.0,"total_display":"4,250.00","total_whole":"4,250","shares_owned_after":33567955.0,"shares_owned_after_display":"33,567,955","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-03","filed_date":"2009-12-04","scope":"insider"},{"id":6016301,"accession":"0001140361-09-028211","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-09-028211","line_url":"/filing/0001140361-09-028211#line-3","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":0.88,"price_display":"0.88","price_state":"stated","total_value":13200.0,"total_display":"13,200.00","total_whole":"13,200","shares_owned_after":33572955.0,"shares_owned_after_display":"33,572,955","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-02","filed_date":"2009-12-04","scope":"insider"},{"id":6016298,"accession":"0001140361-09-028211","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-028211","line_url":"/filing/0001140361-09-028211#line-2","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":0.84,"price_display":"0.84","price_state":"stated","total_value":12600.0,"total_display":"12,600.00","total_whole":"12,600","shares_owned_after":33587955.0,"shares_owned_after_display":"33,587,955","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-01","filed_date":"2009-12-04","scope":"insider"},{"id":6016295,"accession":"0001140361-09-028211","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-028211","line_url":"/filing/0001140361-09-028211#line-1","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":0.85,"price_display":"0.85","price_state":"stated","total_value":17000.0,"total_display":"17,000.00","total_whole":"17,000","shares_owned_after":33602955.0,"shares_owned_after_display":"33,602,955","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-30","filed_date":"2009-12-04","scope":"insider"},{"id":5728896,"accession":"0001140361-09-027649","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-09-027649","line_url":"/filing/0001140361-09-027649#line-3","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34000.0,"shares_display":"34,000","price_per_share":0.89,"price_display":"0.89","price_state":"stated","total_value":30260.0,"total_display":"30,260.00","total_whole":"30,260","shares_owned_after":33622955.0,"shares_owned_after_display":"33,622,955","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-25","filed_date":"2009-11-30","scope":"insider"},{"id":5728895,"accession":"0001140361-09-027649","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-027649","line_url":"/filing/0001140361-09-027649#line-2","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30045.0,"shares_display":"30,045","price_per_share":0.84,"price_display":"0.84","price_state":"stated","total_value":25237.8,"total_display":"25,237.80","total_whole":"25,238","shares_owned_after":33656955.0,"shares_owned_after_display":"33,656,955","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-24","filed_date":"2009-11-30","scope":"insider"},{"id":5728894,"accession":"0001140361-09-027649","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-027649","line_url":"/filing/0001140361-09-027649#line-1","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":0.93,"price_display":"0.93","price_state":"stated","total_value":9300.0,"total_display":"9,300.00","total_whole":"9,300","shares_owned_after":33687000.0,"shares_owned_after_display":"33,687,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-23","filed_date":"2009-11-30","scope":"insider"},{"id":5989130,"accession":"0001140361-09-027230","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-027230","line_url":"/filing/0001140361-09-027230#line-1","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42500.0,"shares_display":"42,500","price_per_share":0.89,"price_display":"0.89","price_state":"stated","total_value":37825.0,"total_display":"37,825.00","total_whole":"37,825","shares_owned_after":33697000.0,"shares_owned_after_display":"33,697,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-20","filed_date":"2009-11-23","scope":"insider"},{"id":5816547,"accession":"0001140361-09-027061","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-027061","line_url":"/filing/0001140361-09-027061#line-2","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":0.89,"price_display":"0.89","price_state":"stated","total_value":35600.0,"total_display":"35,600.00","total_whole":"35,600","shares_owned_after":33739500.0,"shares_owned_after_display":"33,739,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-19","filed_date":"2009-11-23","scope":"insider"},{"id":5816544,"accession":"0001140361-09-027061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-027061","line_url":"/filing/0001140361-09-027061#line-1","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":0.88,"price_display":"0.88","price_state":"stated","total_value":8800.0,"total_display":"8,800.00","total_whole":"8,800","shares_owned_after":33779500.0,"shares_owned_after_display":"33,779,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-18","filed_date":"2009-11-23","scope":"insider"},{"id":5664899,"accession":"0001140361-09-026701","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-026701","line_url":"/filing/0001140361-09-026701#line-2","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":0.88,"price_display":"0.88","price_state":"stated","total_value":8800.0,"total_display":"8,800.00","total_whole":"8,800","shares_owned_after":33789500.0,"shares_owned_after_display":"33,789,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-17","filed_date":"2009-11-18","scope":"insider"},{"id":5664898,"accession":"0001140361-09-026701","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-026701","line_url":"/filing/0001140361-09-026701#line-1","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":0.87,"price_display":"0.87","price_state":"stated","total_value":26100.0,"total_display":"26,100.00","total_whole":"26,100","shares_owned_after":33799500.0,"shares_owned_after_display":"33,799,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-16","filed_date":"2009-11-18","scope":"insider"},{"id":5653747,"accession":"0001140361-09-026429","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-026429","line_url":"/filing/0001140361-09-026429#line-2","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":0.86,"price_display":"0.86","price_state":"stated","total_value":8600.0,"total_display":"8,600.00","total_whole":"8,600","shares_owned_after":33829500.0,"shares_owned_after_display":"33,829,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-13","filed_date":"2009-11-16","scope":"insider"},{"id":5653746,"accession":"0001140361-09-026429","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-026429","line_url":"/filing/0001140361-09-026429#line-1","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":0.86,"price_display":"0.86","price_state":"stated","total_value":17200.0,"total_display":"17,200.00","total_whole":"17,200","shares_owned_after":33839500.0,"shares_owned_after_display":"33,839,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-12","filed_date":"2009-11-16","scope":"insider"},{"id":5816502,"accession":"0001140361-09-025787","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-025787","line_url":"/filing/0001140361-09-025787#line-2","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":0.85,"price_display":"0.85","price_state":"stated","total_value":17000.0,"total_display":"17,000.00","total_whole":"17,000","shares_owned_after":33859500.0,"shares_owned_after_display":"33,859,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-11","filed_date":"2009-11-12","scope":"insider"},{"id":5816499,"accession":"0001140361-09-025787","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-025787","line_url":"/filing/0001140361-09-025787#line-1","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":0.82,"price_display":"0.82","price_state":"stated","total_value":16400.0,"total_display":"16,400.00","total_whole":"16,400","shares_owned_after":33879500.0,"shares_owned_after_display":"33,879,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-10","filed_date":"2009-11-12","scope":"insider"},{"id":5858509,"accession":"0001140361-09-025205","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-025205","line_url":"/filing/0001140361-09-025205#line-2","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":0.82,"price_display":"0.82","price_state":"stated","total_value":16400.0,"total_display":"16,400.00","total_whole":"16,400","shares_owned_after":33899500.0,"shares_owned_after_display":"33,899,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-06","filed_date":"2009-11-09","scope":"insider"},{"id":5858508,"accession":"0001140361-09-025205","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-025205","line_url":"/filing/0001140361-09-025205#line-1","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":0.82,"price_display":"0.82","price_state":"stated","total_value":8200.0,"total_display":"8,200.00","total_whole":"8,200","shares_owned_after":33919500.0,"shares_owned_after_display":"33,919,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-05","filed_date":"2009-11-09","scope":"insider"},{"id":5669621,"accession":"0001140361-09-025119","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-025119","line_url":"/filing/0001140361-09-025119#line-1","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":0.83,"price_display":"0.83","price_state":"stated","total_value":20750.0,"total_display":"20,750.00","total_whole":"20,750","shares_owned_after":33929500.0,"shares_owned_after_display":"33,929,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-05","filed_date":"2009-11-06","scope":"insider"},{"id":5952526,"accession":"0001140361-09-024348","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-024348","line_url":"/filing/0001140361-09-024348#line-2","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":0.84,"price_display":"0.84","price_state":"stated","total_value":8400.0,"total_display":"8,400.00","total_whole":"8,400","shares_owned_after":33954500.0,"shares_owned_after_display":"33,954,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-02","filed_date":"2009-11-02","scope":"insider"},{"id":5952522,"accession":"0001140361-09-024348","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-024348","line_url":"/filing/0001140361-09-024348#line-1","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":0.86,"price_display":"0.86","price_state":"stated","total_value":25800.0,"total_display":"25,800.00","total_whole":"25,800","shares_owned_after":33964500.0,"shares_owned_after_display":"33,964,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-30","filed_date":"2009-11-02","scope":"insider"},{"id":6016108,"accession":"0001140361-09-024123","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-024123","line_url":"/filing/0001140361-09-024123#line-2","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":0.89,"price_display":"0.89","price_state":"stated","total_value":8900.0,"total_display":"8,900.00","total_whole":"8,900","shares_owned_after":33994500.0,"shares_owned_after_display":"33,994,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-29","filed_date":"2009-10-30","scope":"insider"},{"id":6016104,"accession":"0001140361-09-024123","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-024123","line_url":"/filing/0001140361-09-024123#line-1","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49000.0,"shares_display":"49,000","price_per_share":0.85,"price_display":"0.85","price_state":"stated","total_value":41650.0,"total_display":"41,650.00","total_whole":"41,650","shares_owned_after":34004500.0,"shares_owned_after_display":"34,004,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-28","filed_date":"2009-10-30","scope":"insider"},{"id":5597794,"accession":"0001140361-09-023745","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-023745","line_url":"/filing/0001140361-09-023745#line-2","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":0.59,"price_display":"0.59","price_state":"stated","total_value":5900.0,"total_display":"5,900.00","total_whole":"5,900","shares_owned_after":34053500.0,"shares_owned_after_display":"34,053,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-22","filed_date":"2009-10-23","scope":"insider"},{"id":5597793,"accession":"0001140361-09-023745","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-023745","line_url":"/filing/0001140361-09-023745#line-1","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":0.6,"price_display":"0.60","price_state":"stated","total_value":6000.0,"total_display":"6,000.00","total_whole":"6,000","shares_owned_after":34063500.0,"shares_owned_after_display":"34,063,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-21","filed_date":"2009-10-23","scope":"insider"},{"id":5709286,"accession":"0001140361-09-023476","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-023476","line_url":"/filing/0001140361-09-023476#line-1","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":0.75,"price_display":"0.75","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","total_whole":"15,000","shares_owned_after":34073500.0,"shares_owned_after_display":"34,073,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-15","filed_date":"2009-10-19","scope":"insider"},{"id":6086326,"accession":"0001140361-09-023331","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-023331","line_url":"/filing/0001140361-09-023331#line-1","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":0.77,"price_display":"0.77","price_state":"stated","total_value":7700.0,"total_display":"7,700.00","total_whole":"7,700","shares_owned_after":34093500.0,"shares_owned_after_display":"34,093,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-13","filed_date":"2009-10-15","scope":"insider"},{"id":5626261,"accession":"0001140361-09-022230","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-022230","line_url":"/filing/0001140361-09-022230#line-2","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":0.81,"price_display":"0.81","price_state":"stated","total_value":8100.0,"total_display":"8,100.00","total_whole":"8,100","shares_owned_after":34103500.0,"shares_owned_after_display":"34,103,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-30","filed_date":"2009-10-01","scope":"insider"},{"id":5626260,"accession":"0001140361-09-022230","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-022230","line_url":"/filing/0001140361-09-022230#line-1","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":0.81,"price_display":"0.81","price_state":"stated","total_value":24300.0,"total_display":"24,300.00","total_whole":"24,300","shares_owned_after":34113500.0,"shares_owned_after_display":"34,113,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-29","filed_date":"2009-10-01","scope":"insider"},{"id":5786203,"accession":"0001140361-09-021939","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-021939","line_url":"/filing/0001140361-09-021939#line-2","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":0.85,"price_display":"0.85","price_state":"stated","total_value":17000.0,"total_display":"17,000.00","total_whole":"17,000","shares_owned_after":34143500.0,"shares_owned_after_display":"34,143,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-28","filed_date":"2009-09-29","scope":"insider"},{"id":5786201,"accession":"0001140361-09-021939","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-021939","line_url":"/filing/0001140361-09-021939#line-1","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17500.0,"shares_display":"17,500","price_per_share":0.88,"price_display":"0.88","price_state":"stated","total_value":15400.0,"total_display":"15,400.00","total_whole":"15,400","shares_owned_after":34163500.0,"shares_owned_after_display":"34,163,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-25","filed_date":"2009-09-29","scope":"insider"},{"id":5690217,"accession":"0001140361-09-021763","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-021763","line_url":"/filing/0001140361-09-021763#line-2","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":0.86,"price_display":"0.86","price_state":"stated","total_value":17200.0,"total_display":"17,200.00","total_whole":"17,200","shares_owned_after":34181000.0,"shares_owned_after_display":"34,181,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-24","filed_date":"2009-09-25","scope":"insider"},{"id":5690216,"accession":"0001140361-09-021763","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-021763","line_url":"/filing/0001140361-09-021763#line-1","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":0.86,"price_display":"0.86","price_state":"stated","total_value":8600.0,"total_display":"8,600.00","total_whole":"8,600","shares_owned_after":34201000.0,"shares_owned_after_display":"34,201,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-23","filed_date":"2009-09-25","scope":"insider"},{"id":5669581,"accession":"0001140361-09-021458","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-09-021458","line_url":"/filing/0001140361-09-021458#line-4","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":18000.0,"total_display":"18,000.00","total_whole":"18,000","shares_owned_after":34211000.0,"shares_owned_after_display":"34,211,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-21","filed_date":"2009-09-22","scope":"insider"},{"id":5669580,"accession":"0001140361-09-021458","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-09-021458","line_url":"/filing/0001140361-09-021458#line-3","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":18000.0,"total_display":"18,000.00","total_whole":"18,000","shares_owned_after":34231000.0,"shares_owned_after_display":"34,231,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-18","filed_date":"2009-09-22","scope":"insider"},{"id":5669579,"accession":"0001140361-09-021458","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-021458","line_url":"/filing/0001140361-09-021458#line-2","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17900.0,"shares_display":"17,900","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":16289.0,"total_display":"16,289.00","total_whole":"16,289","shares_owned_after":34251000.0,"shares_owned_after_display":"34,251,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-16","filed_date":"2009-09-22","scope":"insider"},{"id":5669578,"accession":"0001140361-09-021458","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-021458","line_url":"/filing/0001140361-09-021458#line-1","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":0.95,"price_display":"0.95","price_state":"stated","total_value":19000.0,"total_display":"19,000.00","total_whole":"19,000","shares_owned_after":34268900.0,"shares_owned_after_display":"34,268,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-15","filed_date":"2009-09-22","scope":"insider"},{"id":5642652,"accession":"0001140361-09-021344","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-021344","line_url":"/filing/0001140361-09-021344#line-1","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":0.97,"price_display":"0.97","price_state":"stated","total_value":19400.0,"total_display":"19,400.00","total_whole":"19,400","shares_owned_after":34288900.0,"shares_owned_after_display":"34,288,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-14","filed_date":"2009-09-21","scope":"insider"},{"id":5942736,"accession":"0001140361-09-020852","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-09-020852","line_url":"/filing/0001140361-09-020852#line-6","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":0.95,"price_display":"0.95","price_state":"stated","total_value":28500.0,"total_display":"28,500.00","total_whole":"28,500","shares_owned_after":34308900.0,"shares_owned_after_display":"34,308,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-10","filed_date":"2009-09-14","scope":"insider"},{"id":5942734,"accession":"0001140361-09-020852","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001140361-09-020852","line_url":"/filing/0001140361-09-020852#line-5","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":27000.0,"total_display":"27,000.00","total_whole":"27,000","shares_owned_after":34338900.0,"shares_owned_after_display":"34,338,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-09","filed_date":"2009-09-14","scope":"insider"},{"id":5942732,"accession":"0001140361-09-020852","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-09-020852","line_url":"/filing/0001140361-09-020852#line-4","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":0.89,"price_display":"0.89","price_state":"stated","total_value":17800.0,"total_display":"17,800.00","total_whole":"17,800","shares_owned_after":34368900.0,"shares_owned_after_display":"34,368,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-08","filed_date":"2009-09-14","scope":"insider"},{"id":5942731,"accession":"0001140361-09-020852","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-09-020852","line_url":"/filing/0001140361-09-020852#line-3","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":0.84,"price_display":"0.84","price_state":"stated","total_value":16800.0,"total_display":"16,800.00","total_whole":"16,800","shares_owned_after":34388900.0,"shares_owned_after_display":"34,388,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-04","filed_date":"2009-09-14","scope":"insider"},{"id":5942729,"accession":"0001140361-09-020852","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-020852","line_url":"/filing/0001140361-09-020852#line-2","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":0.85,"price_display":"0.85","price_state":"stated","total_value":17000.0,"total_display":"17,000.00","total_whole":"17,000","shares_owned_after":34408900.0,"shares_owned_after_display":"34,408,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-03","filed_date":"2009-09-14","scope":"insider"},{"id":5942728,"accession":"0001140361-09-020852","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-020852","line_url":"/filing/0001140361-09-020852#line-1","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":0.88,"price_display":"0.88","price_state":"stated","total_value":8800.0,"total_display":"8,800.00","total_whole":"8,800","shares_owned_after":34428900.0,"shares_owned_after_display":"34,428,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-01","filed_date":"2009-09-14","scope":"insider"},{"id":5626219,"accession":"0001140361-09-019735","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-019735","line_url":"/filing/0001140361-09-019735#line-2","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":9100.0,"total_display":"9,100.00","total_whole":"9,100","shares_owned_after":34438900.0,"shares_owned_after_display":"34,438,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-25","filed_date":"2009-08-26","scope":"insider"},{"id":5626218,"accession":"0001140361-09-019735","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-019735","line_url":"/filing/0001140361-09-019735#line-1","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":0.86,"price_display":"0.86","price_state":"stated","total_value":10320.0,"total_display":"10,320.00","total_whole":"10,320","shares_owned_after":34448900.0,"shares_owned_after_display":"34,448,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-24","filed_date":"2009-08-26","scope":"insider"},{"id":5843154,"accession":"0001140361-09-019137","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-09-019137","line_url":"/filing/0001140361-09-019137#line-4","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":0.87,"price_display":"0.87","price_state":"stated","total_value":8700.0,"total_display":"8,700.00","total_whole":"8,700","shares_owned_after":34460900.0,"shares_owned_after_display":"34,460,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-14","filed_date":"2009-08-17","scope":"insider"},{"id":5843152,"accession":"0001140361-09-019137","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-09-019137","line_url":"/filing/0001140361-09-019137#line-3","is_derivative":false,"issuer_cik":"0001379006","issuer_name":"NANOVIRICIDES, INC.","issuer_ticker":"NNVC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001379006","owner_cik":"0001451613","owner_name":"Theracour Pharma, Inc.","owner_display_name":"Theracour Pharma, Inc.","owner_url":"/insider/0001451613","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":0.96,"price_display":"0.96","price_state":"stated","total_value":19200.0,"total_display":"19,200.00","total_whole":"19,200","shares_owned_after":34470900.0,"shares_owned_after_display":"34,470,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-12","filed_date":"2009-08-17","scope":"insider"}],"collapsed":true,"next_cursor":"2009-08-12|5843152","ledger_fault":false,"count":{"value":92,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":92,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":92},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001379006","name":"NANOVIRICIDES, INC.","url":"/issuer/0001379006","role":"Ten percent owner","n_filings":46,"first_seen":"2008-12-18","last_seen":"2013-02-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001451613","retrieved_at":"2026-08-22T08:48:47+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}